###### Strengths and limitations of this study

-   Repeated assessment of environmental chemical exposure during gestation, infancy, childhood and adolescence allows us to investigate periods of heightened susceptibility.

-   High-quality and longitudinal measurements of physical, behavioural and mental health provide opportunities to examine trajectories of multiple childhood health outcomes.

-   Attrition over the course of follow-up is one of the main limitations of the Health Outcomes and Measures of the Environment (HOME) Study (42% attrition at 12-year study visit).

-   The modest sample size limits the statistical power to examine relatively small effects or clinical diagnoses.

-   Our eligibility criteria may reduce the generalisability of our findings to other populations.

Introduction {#s1}
============

Environmental exposures experienced by the gametes, fetus, infant, child or adolescent may increase the risk of later life disease. Well-established examples of environmental factors affecting later-life health include the increased risk of vaginal clear cell carcinoma and several reproductive disorders following in utero diethylstilbestrol exposure, as well as cognitive decrements in children with prenatal mercury or childhood lead exposure.[@R1] These studies indicate the presence of periods of heightened developmental susceptibility to some exposures.

There is concern that exposure to environmental chemicals during susceptible periods may increase the risk of adverse childhood health outcomes.[@R5] Work from our research group shows that exposure to environmental chemicals and their mixtures is associated with reduced fetal growth,[@R8] neurobehavioural deficits,[@R10] respiratory problems[@R12] and excess adiposity.[@R14] Moreover, we found that the association of some chemicals with childhood health depends on the timing of exposure.[@R11] However, there are substantial gaps in our knowledge about the persistence of these effects into adolescence, especially for outcomes unique to adolescence, including puberty,[@R16] bone health[@R17] and internalising disorders.[@R18]

Relatedly, there is little research examining the impact of adolescent chemical exposures on health. Adolescence may be a period of heightened susceptibility as studies of the Nigerian Civil War and Cambodian famine indicate that famine during adolescence had greater impacts on adult height than famine during other periods.[@R19] Moreover, some aspects of gestational and adolescent development share common biological pathways (eg, neurodevelopment).[@R21] Thus, exposure to chemicals during adolescence may adversely affect neurobehaviour, bone health, asthma/allergy, obesity and cardiometabolic health.

Ensuring that adolescents achieve their full potential is of profound public health importance given that the 1.2 billion adolescents worldwide (16% of the population) will become tomorrow's leaders, labourers and parents.[@R22] Interventions targeting adolescents have great potential for high economic and social returns.[@R23] Thus, we conducted a new follow-up on adolescents from the Health Outcomes and Measures of the Environment (HOME) Study to fill critical gaps in our knowledge about the potential effects of chemical exposures across the lifespan on adolescent health.

Cohort description {#s2}
==================

Overview {#s2-1}
--------

The HOME Study is a prospective pregnancy and birth cohort study that enrolled 468 pregnant women from the greater Cincinnati, Ohio region from 2003 to 2006 and conducted longitudinal follow-up on children shortly after birth and at 4 weeks and 1, 2, 3, 4, 5 and 8 years of age.[@R24] As previously described, the HOME Study was designed to quantify the effects of low-level environmental toxicant exposures on children's risk of allergy, asthma, obesity and neurobehavioural disorders.[@R24] During pregnancy and childhood, we repeatedly collected maternal and child biospecimens and environmental samples, and administeredta neurobehavioural batteries, clinical examinations and questionnaires longitudinally to both mothers and their children.

We completed a new phase of data collection when children were 12 years of age (range: 11--14), at which time we assessed several dimensions of children's health and well-being that were not previously measured ([table 1](#T1){ref-type="table"}). This latest phase of follow-up included detailed assessments of internalising symptoms (ie, anxiety and depression), neuroimaging, body composition, bone health and cardiometabolic health, as well as continued assessment of children's allergies, asthma, respiratory health, anthropometry and neurobehaviour. In addition, we assessed children's diet, physical activity and sleep, and collected an array of biospecimens from children. Moreover, we measured leucocyte DNA methylation and metabolomics during gestation, childhood and adolescence, as these may be important health outcomes or potential mediators in the relationships between early life exposures and child health. Finally, we assessed mother's anthropometry, blood pressure and several features of her mental health, as well as collected information about the health history of fathers and grandparents.

###### 

Summary of measurements collected from HOME Study children and their mothers at 12 years of age (Cincinnati, Ohio, 2016--2018)

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Measurement category                                                          Measurement or sample
  ----------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------
  Internalising symptoms and neurobehaviour                                     Anxiety

  Depression                                                                    

  Memory                                                                        

  Fine motor skills                                                             

  Executive functions                                                           

  Social behaviours                                                             

  Social problem solving                                                        

  Problem behaviours (eg, attention-deficit/hyperactivity disorder)\            
  Adaptive behaviours                                                           

  Brain imaging                                                                 MRI\
                                                                                Magnetic resonance spectroscopy\
                                                                                Diffusion MRI

  Functional MRI                                                                

  Body composition and bone health                                              Fat and lean mass, visceral fat mass

  Whole body, lumbar spine, forearm, and hip bone mineral content and density   

  Weight, height and waist/hip circumferences                                   

  Cardiometabolic risk factors                                                  Blood pressure

  Heart rate                                                                    

  Fasting insulin and glucose                                                   

  Fasting HDL, LDL, total cholesterol and triglycerides                         

  Leptin and adiponectin                                                        

  Central adiposity                                                             

  Biospecimens                                                                  Blood---serum and whole blood

  Buccal cells                                                                  

  Hair                                                                          

  Stool                                                                         

  Urine                                                                         

  Shed deciduous teeth                                                          

  Chemical exposures                                                            Phthalates, phenols, polybrominated diphenyl ether flame retardants, organophosphate flame retardants and perfluoroalkyl substances

  Other biomarkers                                                              High-resolution metabolomics

  Leucocyte DNA methylation                                                     

  Vitamin D metabolites                                                         

  Urine drug screen                                                             

  Physical activity                                                             Questionnaire

  Accelerometer                                                                 

  Diet                                                                          3×24 hour Dietary recalls\
                                                                                Eating behaviours

  Sleep                                                                         Questionnaire

  Actigraphy                                                                    

  Pubertal development                                                          Self-assessed Tanner staging\
                                                                                Lutenising and follicle-stimulating hormones\
                                                                                Estradiol, testosterone and dehydroepiandrosterone sulfate

  Questionnaires                                                                Substance Use

  School Outcomes                                                               

  Sociodemographics                                                             

  Mother--Child Relationship                                                    

  Family Medical History                                                        

  Mother's Mental Health and ADHD Symptoms                                      

  Environmental Exposures                                                       
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ADHD, Attention-deficit/hyperactivity disorder; HDL, high-density lipoprotein; HOME, The Health Outcomes and Measures of the Environment; LDL, low-density lipoprotein.

Eligibility and follow-up {#s2-2}
-------------------------

From March 2003 to January 2006, we recruited 468 pregnant women living in a five-county region of the Cincinnati, Ohio metropolitan area (Butler, Clermont, Hamilton and Warren counties) and Northern Kentucky (Campbell County) to participate in a longitudinal pregnancy and birth cohort study. Sixty-seven women dropped out during pregnancy during the run-in phase of a randomised controlled trial of residential lead and injury hazard controls nested within the cohort.[@R25] From 2003 to 2014, we conducted up to 11 in-person follow-up visits on 410 eligible children (390 singletons and 10 twin sets) at the delivery hospital, our study clinic or participant's homes when children were approximately 1 day, 4 weeks, and 1, 2, 3, 4, 5 and 8 years of age; follow-up rates ranged from 48% (age 4 years) to 94% (age 4 weeks).

From June 2016 to April 2019, we invited 441 children (offspring of 431 mothers; 92% of all live births) and their birth mother or primary caregiver (referred to as mother hereafter) to return to our study clinic when children were on average 12.4 years of age (SD: 0.7, range: 11--14.1). We did not contact 38 (8%) participants because the fetus or child was deceased, they did not provide prenatal biospecimens or they indicated that they did not want to be contacted for future study visits. We restricted the upper limit of our age range to \<14.1 years to reduce the variability of our study outcomes related to age. At the 12-year study visit, we attempted to contact 30 mothers who dropped out during the run-in phase of the randomised trial; 10 of these children (8 singletons and 1 twin set) completed the 12-year study visit.

We completed follow-up on 256 children (242 singletons and 7 twin sets) (58.0% of children). Nine children conducted follow-up by telephone or mail, only completing study-related questionnaires. Among those 185 who did not complete follow-up, 99 (54%) refused to participate, 23 (12%) were lost to follow-up and 63 (34%) turned 14 years old before we could complete follow-up.

We employed conventional methods like newsletters, mailings, providing Saturday visits, and frequent phone calls, text messages and emails to study participants to increase participation at this study visit. In addition, we used the LexisNexis Accurint service to obtain updated contact information for mothers and contacted participant's friends or family members. We also created a Facebook page that we used to announce study visits, publicise study results, share other study-related information and communicate with participants. Finally, we visited some participant's residences to tell them about the study visit, leave information and a small gift, and attempt to schedule a follow-up visit.

Randomised trial {#s2-3}
----------------

Nested within the HOME Study is a randomised clinical trial of two interventions designed to reduce residential lead and injury hazards; we previously described the results of these trials.[@R25] Briefly, we randomly assigned pregnant women to either the residential lead or injury hazard intervention. By 32 weeks of gestation and before delivery, the lead hazard intervention group received a combination of activities designed to reduce residential lead exposure. Families assigned to the control group received an injury prevention intervention before children were aged 6 months.

Patient and public involvement {#s2-4}
------------------------------

A community advisory board provided feedback on the original design of the HOME Study before the study began. Before initiating any new follow-up, we conducted pilot testing to ensure that the visit length and types of assessments were appropriate. At more recent childhood follow-up visits, we collected information regarding the visit length and experience from participants and used this to inform the development of subsequent visits. We previously reported back concentrations of environmental chemical biomarkers to participants while also providing contextual information. Finally, we reported clinically significant findings to participants and their medical providers (eg, hypercholesterolaemia).

Adolescent follow-up measurements {#s2-6}
---------------------------------

At the latest HOME Study visit, we conducted detailed assessments of children's neurobehaviour, body composition, bone health and cardiometabolic risk. In addition, we assessed multiple risk factors for these health outcomes that might be confounders, mediators or modifiers of associations between chemical exposures and these health outcomes ([table 1](#T1){ref-type="table"}).

### Neurobehaviour and neuroimaging {#s2-6-1}

We measured several domains of children's neurobehaviour, with an emphasis on internalising symptoms. To assess children's anxiety, children completed the Spence Children's Anxiety Scale, and both mothers and children completed the Screen for Child Anxiety Related Disorders.[@R27] Children and their mothers self-reported depressive symptoms with the Child Depression Inventory-II and Beck Depression Inventory-II, respectively.[@R29] Both mothers and children completed the Behavior Rating Inventory of Executive Function and Behavioral Assessment System for Children-3 to assess children's executive function and problem/adaptive behaviours, respectively.[@R31] We assessed children's social behaviours by administering the Social Responsiveness Scale-2 to mothers, the Social Skills Improvement System scale to mothers and children, and the Social Problem Solving Scale to children.[@R33] We administered the Child and Adolescent Memory Profile and Grooved Pegboard to assess children's memory and fine motor skills, respectively.[@R36] Finally, mothers completed the Child Eating Behavior Questionnaire to measure eight dimensions of children's appetite and eating behaviours.[@R38]

Using a 3 T, whole-body magnetic resonance scanner with a 32-channel head coil, we conducted a neuroimaging protocol on 199 (188 singletons and 11 twins (1 randomly selected)) children without braces, metal implants, significant anxiety or claustrophobia, prior brain surgeries or communication barriers. The measurements included volumetric MRI, proton magnetic resonance spectroscopy (MRS), diffusion tensor imaging and functional MRI (fMRI) (details in [table 2](#T2){ref-type="table"}). Two fMRI techniques were acquired: a block paradigm design with a continuous performance task using a facial affect probe and a paradigm of free resting-state acquisition for functional connectivity analyses. [Figure 1](#F1){ref-type="fig"} shows the results for these four modalities from one cohort participant.

![Illustrations of the multimodal neuroimaging protocol acquired from a HOME Study participant. Top left, a representation of white matter fibre tracks emerging from the cingulum determined using diffusion tensor imaging. Top centre, a spectral plot of relative concentrations of select neurochemicals within the perigenual anterior cingulate cortex acquired with MRS). Top right, a calculated activation MAP from a single slice of the brain during a continuous performance task that was measured with functional MRI. Bottom, anatomical images acquired with MRI; slices are oriented in the sagittal, coronal and axial planes. The yellow box denotes the location and volume (8 cm^3^) where the MRS sampling was acquired. The anatomical images are acquired at high resolution, on the order of 1 mm^3^, to enable volumetric and morphometric analyses. All images courtesy of Travis Beckwith, PhD and Kim M Cecil, PhD. HOME, Health Outcomes and Measures of the Environment; MAP, mean apparent propagator; MRS, magnetic resonance spectroscopy.](bmjopen-2019-034838f01){#F1}

###### 

Neuroimaging measures obtained from HOME Study children at 12 years of age

  Measure                Method             Outcome variables                                                                          Purpose
  ---------------------- ------------------ ------------------------------------------------------------------------------------------ --------------------------------------------------------------------------------------
  Structure              Volumetric         Volume (mm^3^)                                                                             Total grey matter, white matter, CSF and regional volumes; cortical thickness
  Organisation           Diffusion tensor   Fractional anisotropy, mean diffusivity, axial diffusivity, radial diffusivity (mm^2^/s)   White matter (axonal and myelin) architecture and integrity; structural connectivity
  Structure & function   MRS                Concentrations of *N*-acetylaspartate, creatine, choline, myo-inositol and glutamate       Neural structure and metabolism
  Function               fMRI               Signal activation; global and local efficiency; transivity from networks                   Functional connectivity features of the neural networks

CSF, cerebrospinal fluid; fMRI, functional MRI; HOME, The Health Outcomes and Measures of the Environment; MRS, magnetic resonance spectroscopy.

### Body composition, bone health and anthropometry {#s2-6-2}

We measured adipose and lean tissue mass of the whole body, extremities and abdomen as well as visceral fat using dual-energy X-ray absorptiometry with a Hologic Horizon densitometer. Using this same instrument, we estimated bone mineral content and density of the whole body, lumbar spine, hip and forearm. Experienced research assistants measured weight, standing height, and waist and hip circumferences in triplicate.

### Biospecimens {#s2-6-3}

We collected fasting blood, buccal cells, hair, urine and stool samples from children. To ensure that children arrived in a fasting state, we reminded parents the night before the study visit to have their child begin fasting at bedtime. In addition, we asked children if they ate anything since bedtime last night and brought children back for a fasting blood draw at a later date if they broke their fast before the study visit. In the 2 weeks after the study visit, children collected up to three stool samples on faecal occult blood test cards.[@R40]

Children returning for in-person visits provided urine (n=247, 95%), buccal cells (n=246, 96%), hair (n=230, 90%), blood (n=209, 82%) and up to three stool samples (n=172, 67%). Missing blood collections were due to refusals (n=28, 11%) or difficulties with the blood collection (eg, fainting) (n=19, 7%). We also collected 1159 shed deciduous teeth from 205 children.[@R41] Blood and stool samples are stored in −80°C freezers, whereas buccal cells and urine are stored at −20°C. Hair and teeth are stored at ambient indoor temperature in locked cabinets.

### Cardiometabolic risk markers {#s2-6-4}

We assessed several features of children's cardiometabolic health that have been associated with increased risk of adult cardiovascular disease.[@R42] We measured waist circumference and dual-energy X-ray absorptiometry-derived measures of central adiposity to classify children as centrally obese.[@R46] We took three sitting blood pressure and heart rate measurements, each 1 min apart, using a Dinamap Pro100 automated monitor.[@R48] Finally, we quantified insulin, glucose, total cholesterol, low-density and high-density lipoproteins, triglyceride and haemoglobin A1C concentrations in fasting serum or whole blood samples.

### Chemical exposures {#s2-6-5}

Using biomarkers and questionnaires, we measured or plan to measure children's exposure to an array of environmental chemicals that have been implicated in the risk of neurobehavioural disorders and internalising symptoms, obesity, bone health and cardiometabolic dysfunction.[@R6] This includes serum concentrations of polychlorinated biphenyls (PCBs), per- and polyfluoroalkyl substances (PFAS) and polybrominated diphenyl ethers (PBDEs), as well as urinary concentrations of phthalates, phthalate replacements, phenols, phenol replacements and organophosphate flame retardants. We also administered questionnaires to parents and children about behaviours and the use of products related to these and other chemical exposures.

### Physical activity, diet and sleep {#s2-6-6}

We measured physical activity, diet and sleep as potential confounders of chemical exposure--outcome associations to account for variation in our outcomes related to them, or to investigate them as potential mediators or modifiers of associations between chemical exposures and childhood health. We measured physical activity over 7 days with an Actigraph accelerometer and administered a physical activity questionnaire.[@R51] Trained research staff administered three 24-hour dietary recalls to children using the Nutrition Data Systems for Research software and foods database to assess total daily energy and macronutrient and micronutrient intake; we also calculated 2015 Healthy Eating Index scores.[@R54] Mothers and their children completed the Adolescent Sleep Habits Questionnaire. In addition, we are able to derive sleep measures from the actigraphy data.[@R55]

### Other biomarkers {#s2-6-7}

We measured other biomarkers including leucocyte DNA methylation,[@R57] high-resolution metabolomics,[@R58] gonadal hormone concentrations and vitamin D metabolite concentrations. We also conducted a drug screen on children's urine using a clinical drug panel assay.

### Other data {#s2-6-8}

We measured sociodemographic factors including maternal (or caregiver) and child race/ethnicity, age, education, marital status, employment, insurance and household income. We assessed mother's (or caregiver's) psychological symptoms and parenting relationship with the child using the Symptom Checklist-90-Revised and Parenting Relationship Questionnaire, respectively.[@R59] We also measured mother's weight, standing height, waist and hip circumference, blood pressure and heart rate as described earlier. In addition, we administered a questionnaire about the mother's and biological or non-biological father's history of cardiometabolic disease. To assess child puberty, we measured serum gonadal hormone concentrations, had girls self-report if they attained menarche, and had children self-stage their pubic hair (boys and girls) and breast (girls only) development according to images illustrating the different Tanner stages of development that were accompanied by the age-appropriate language we developed during pilot testing. We also assessed children's usage of electronic media, cigarettes and e-cigarettes. Finally, mothers reported the biological or non-biological father's education, weight and height. We also measured the intelligence quotient of 127 biological or non-biological fathers.

Findings to date {#s3}
================

Baseline sociodemographic and perinatal characteristics of mother--child pairs who completed follow-up were similar to the original cohort ([table 3](#T3){ref-type="table"}). Children's mothers were predominately non-Hispanic white (60.5%), college-educated (48%), multiparous (55.5%) and non-smokers during pregnancy (84.0%).

###### 

Sociodemographic, perinatal and infant characteristics of HOME Study woman--child dyads eligible for follow-up (n=441) and those who completed follow-up at 12 years of age (n=256)\*

  Characteristic                             N (%)/mean (SD) at enrolment†   N (%)/mean (SD) at 12-year visit
  ------------------------------------------ ------------------------------- ----------------------------------
  Maternal race                                                              
   Non-Hispanic white                        253 (57.4)                      155 (60.5)
   Non-Hispanic black                        130 (29.5)                      88 (34.4)
   American Indian, Asian/Pacific/Hispanic   27 (6.1)                        13 (5.1)
   Missing                                   31 (7.0)                        0 (0)
  Maternal age at delivery (years)                                           
   18--\<25                                  98 (22.2)                       62 (24.2)
   25--\<30                                  122 (27.7)                      72 (28.1)
   30--\<35                                  127 (28.8)                      86 (33.6)
   [\>]{.ul}35                               59 (13.4)                       36 (14.1)
   Missing                                   35 (7.9)                        0 (0)
  Maternal education                                                         
   Some high school                          40 (9.1)                        21 (8.2)
   High school or GED                        52 (11.8)                       31 (12.1)
   Some college or technical school          104 (23.6)                      72 (28.1)
   [\>]{.ul}Bachelor's degree                205 (46.5)                      123 (48.0)
   Missing                                   40 (9.1)                        9 (3.5)
  Parity                                                                     
   Nulliparous                               171 (38.8)                      103 (40.2)
   Multiparous                               220 (49.9)                      142 (55.5)
   Missing                                   50 (11.3)                       11 (4.3)
  Prenatal vitamin use                                                       
   Never                                     48 (10.9)                       28 (10.9)
   Any                                       344 (78.0)                      212 (82.8)
   Missing                                   49 (11.1)                       16 (6.3)
  Household income (US\$ per year)                                           
   \<20 000                                  86 (19.5)                       58 (22.7)
   20 000 to \<40 000                        75 (17.0)                       45 (17.6)
   40 000 to \<80 000                        128 (29.0)                      77 (30.1)
   [\>]{.ul}80 000                           104 (23.6)                      64 (25.0)
   Missing                                   48 (10.9)                       12 (4.7)
  Smoking during pregnancy†                                                  
   None                                      364 (82.5)                      215 (84.0)
   Any                                       64 (14.5)                       34 (13.3)
   Missing                                   13 (2.9)                        7 (2.7)
  Child sex                                                                  
   Female                                    223 (50.6)                      143 (55.9)
   Male                                      183 (41.5)                      113 (44.1)
   Missing                                   35 (7.9)                        0 (0)
  Infant birth weight (g)                    3329 (643)                      3310 (633)
  Gestational duration (weeks)               38.9 (1.8)                      38.9 (1.8)

\*Among 441, some dropped out during pregnancy before administration of baseline questionnaire. Thus, baseline information was not available for some variables.

†Determined using serum cotinine concentrations at 16 or 26 weeks of gestation or at delivery. Women with a serum cotinine [\>]{.ul}3 ng/mL at any visit were classified as smokers.[@R76]

GED, General Educational Development; HOME, The Health Outcomes and Measures of the Environment.

To date, we have quantified concentrations of phenols, phthalate metabolites, metals, pesticides, PCBs, PBDEs, PFAS and tobacco smoke exposure biomarkers in maternal and child urine, blood or serum samples collected during pregnancy and through 8 years of age ([table 4](#T4){ref-type="table"}). Generally, environmental chemical biomarker concentrations in mothers during pregnancy and children at 8 years of age were similar to those of the US population at the same time.[@R61] One notable exception is that serum perfluorooctanoate concentrations during pregnancy were higher in HOME Study women compared with pregnant women from the USA at the same time.[@R14] We speculate that this might be due to ingestion of drinking water contaminated with perfluorooctanoate released by the DuPont Washington Works plant in Parkersburg, West Virginia.[@R63] We plan to measure concentrations of phenols, phthalate metabolites, organochlorine pesticides, PBDEs, PCBs and PFAS in urine or serum samples collected from children at 12 years of age.

###### 

Description of environmental chemical biomarkers measured in HOME Study mothers during pregnancy and their children at 8 years of age (Cincinnati, Ohio; enrolled 2003--2006)

  Chemical                                                Chemical class                   Matrix   Gestational (mother)   Age 8 years (child)         
  ------------------------------------------------------- -------------------------------- -------- ---------------------- --------------------- ----- ----------------
  Benzophenone-3 (ng/mL)                                  Phenols                          Urine    400                    25 (7.1, 105)         234   24 (6.8, 132)
  Triclosan (ng/mL)                                       Phenols                          Urine    400                    16 (6.4, 49)          234   12 (3.8, 35)
  Bisphenol A (ng/mL)                                     Phenols                          Urine    400                    1.9 (1.0, 3.2)        234   1.6 (1, 3.4)
  ∑Paraben (ng/mL)\*                                      Phenols                          Urine    400                    206 (88, 506)         NA    NA
  Mono-*n*-butyl phthalate (ng/mL)                        Phthalates                       Urine    400                    24 (11, 48)           234   17 (8.4, 31)
  Monobenzyl phthalate (ng/mL)                            Phthalates                       Urine    400                    8.8 (3.9, 18)         234   8.5 (4.6, 23)
  Mono(3-carboxypropyl) phthalate (ng/mL)                 Phthalates                       Urine    400                    2.3 (1.1, 3.8)        234   4.1 (2.3, 7.9)
  Monoisobutyl phthalate (ng/L)                           Phthalates                       Urine    400                    4.7 (2, 9.1)          234   11 (5.6, 20)
  Monoethyl phthalate (ng/mL)                             Phthalates                       Urine    400                    129 (58, 276)         234   24 (11, 55)
  ΣDEHP (ng/mL)†                                          Phthalates                       Urine    400                    87 (44, 164)          234   51 (31, 91)
  Arsenic (ng/mL)                                         Metals                           Urine    321                    4.9 (2.3, 9.3)        NA    NA
  Mercury (ng/mL)                                         Metals                           Blood    388                    0.6 (0.4, 1.0)        203   0.2 (0.2, 0.4)
  Cadmium (ng/mL)                                         Metals                           Urine    321                    0.1 (0.07, 0.2)       NA    NA
  Lead (μg/dL)                                            Metals                           Blood    400                    0.7 (0.5, 0.8)        203   0.7 (0.5, 1.0)
  ∑DAP (ng/mL)‡                                           Organophosphate pesticides       Urine    393                    11 (5.2, 24)          NA    NA
  3-Phenoxybenzoic acid (ng/mL)                           Pyrethroid pesticides            Urine    399                    0.3 (0.1, 0.7)        NA    NA
  *p, p*′-Dichlorodiphenyldichloroethylene (ng/g lipid)   Organochlorine pesticides        Serum    375                    71 (54, 101)          199   42 (30, 58)
  Hexachlorobenzene (ng/g lipid)                          Organochlorine pesticides        Serum    318                    7.1 (5.7, 8.8)        198   7.8 (5.9, 9)
  Oxychlordane (ng/g lipid)                               Organochlorine pesticides        Serum    310                    5.1 (3.6, 7.2)        174   2.8 (2.3, 5.4)
  *trans*-Nonachlor (ng/g lipid)                          Organochlorine pesticides        Serum    325                    7.4 (5.1, 12)         196   4.2 (2.4, 7.2)
  ∑~4~PCB (ng/g lipid)§                                   Polychlorinated biphenyls        Serum    363                    30 (21, 43)           198   12 (7.3, 22)
  Polybrominated diphenyl ether-47 (ng/g lipid)           Polybrominated diphenyl ethers   Serum    375                    19 (11, 35)           199   19 (10, 39)
  Perfluorohexane sulfonate (ng/mL)                       Perfluoroalkyl substances        Serum    370                    1.5 (0.9, 2.3)        200   1.3 (0.9, 2)
  Perfluorooctanoate (ng/mL)                              Perfluoroalkyl substances        Serum    370                    5.4 (3.6, 7.6)        200   2.4 (1.7, 3.1)
  Perfluorooctane sulfonate (ng/mL)                       Perfluoroalkyl substances        Serum    370                    13 (9, 18)            200   3.6 (2.7, 4.9)
  Perfluorononanoate (ng/mL)                              Perfluoroalkyl substances        Serum    370                    0.9 (0.7, 1.1)        200   0.7 (0.5, 1)
  Cotinine (ng/mL)                                        Tobacco smoke exposure           Serum    400                    0.03 (0.01, 0.2)      NA    NA

\*∑Paraben is the molar sum of methylparaben, propylparaben and butylparaben (expressed in ng/mL of methylparaben concentrations).

†∑DEHP (di-2-ethylhexyl phthalate) is the molar sum of its urinary metabolites MEHP, MEHHP, MEOHP and MECPP (expressed in ng/mL as MECPP concentration).

‡∑DAP (dialkyl phosphate) is the molar sum of DEDTP, DEP, DETP, DMDTP, DMP and DMTP (expressed in ng/mL as DEDTP concentration).

§∑~4~PCBs (polychlorinated biphenyls) is the sum of PCB 138/158, PCB 118, PCB 153 and PCB 180.

DEDTP, diethyldithiophosphate; DEP, diethylphosphate; DETP, diethylthiophosphate; DMDTP, dimethyldithiophosphate.; DMP, dimethylphosphate; DMTP, dimethylthiophosphate; HOME, The Health Outcomes and Measures of the Environment; MECPP, mono(2-ethyl-5-carboxypentyl) phthalate; MEHHP, mono(2-ethyl-5-hydroxyhexyl) phthalate; MEHP, mono(2-ethylhexyl) phthalate; MEOHP, mono(2-ethyl-5-oxohexyl) phthalate.

At the most recent study visit, 91 (82.1%) boys were Tanner stage 2 or greater for pubic hair development. Among girls, 136 (97.1%) and 134 (95.7%) were Tanner stage 2 or greater for breast and pubic hair development, respectively. In addition, 64 (46.7%) girls achieved menarche at a median age of 11.8 years (range: 11.1--13.2).

Average child anxiety and depression scores were typical for children of this age; 92 (35.9%) and 27 (10.5%) had scores indicative of potential anxiety and depressive disorders, respectively ([table 5](#T5){ref-type="table"}).

###### 

Descriptive statistics of internalising symptoms, body composition, and cardiometabolic risk factors among HOME Study children at the 12-year study visit: stratified by child sex (Cincinnati, Ohio, 2016--2018)

  Measurement                                        Boys   Girls                
  -------------------------------------------------- ------ -------------- ----- --------------
  Internalising behaviours                                                        
   CDI total T-score                                 112    50.1 (8.8)     142   53.3 (11.1)
   CDI Score [\>]{.ul}65\*                                  7 (6.3)              20 (14.1)
   SCARED total score                                112    18.2 (10.4)    142   23.8 (13.8)
   SCARED Score [\>]{.ul}25\*                               25 (22.3)            67 (47.2)
  Body composition                                                                
   Whole-body adipose tissue (% body weight)         105    29.7 (6.6)     130   34.4 (6.6)
   Whole-body lean tissue mass (kg)                  105    33.1 (8.1)     130   32.6 (8.5)
   Whole-body bone mineral content (g)               105    1518 (347)     130   1599 (366)
   Whole-body bone mineral density z-score           105    −0.46 (0.95)   130   −0.38 (0.98)
   BMI (kg/m^2^)                                     110    19.7 (4.6)     136   21.7 (5.9)
   Overweight (BMI z-score \>1)†                            28 (25.4)            58 (42.7)
   Obese (BMI z-score \>2)†                                 4 (3.6)              12 (8.9)
  Cardiometabolic risk factors                                                    
   Glucose (mg/dL)                                   98     93.3 (6.6)     105   90.3 (5.8)
   Elevated glucose (\>100 mg/dL)                           16 (16.3)            5 (4.8)
   Insulin (mIU/mL)                                  98     11.7 (7.2)     106   18.4 (12.2)
   Triglycerides (mg/dL)                             98     88.5 (56.8)    105   86.6 (41.3)
   Elevated triglycerides (\>90 mg/dL)                      30 (30.6)            37 (35.2)
   High-density lipoprotein (mg/dL)                  98     53.8 (13.3)    105   51.7 (10.7)
   Decreased high-density lipoprotein (\<40 mg/dL)          18 (18.4)            14 (13.3)
   Low-density lipoprotein (mg/dL)                   98     88.7 (22.8)    105   85.4 (28)
   Systolic blood pressure (mm Hg)                   110    104 (8.4)      136   103 (9.1)
   Diastolic blood pressure (mm Hg)                  110    58 (5.5)       136   58 (6)

\*Scores above these values are indicative of potentially clinically significant depression or anxiety disorders.

†Overweight and obesity are defined as having an age-specific and sex-specific BMI z-score \>1 and \>2 SD scores based on Centres for Disease Control and Prevention Growth Charts, respectively.

BMI, body mass index; CDI, Child Depression Inventory; HOME, The Health Outcomes and Measures of the Environment; SCARED, Screen for Child Anxiety Related Disorders.

We observed the expected sexual dimorphism in lean/adipose tissue mass that emerges during adolescence with girls having greater percent adipose tissue mass than boys. In addition, 25.4% of boys and 42.7% of girls were overweight or obese based on their body mass index z-score.[@R65] On average, glucose, insulin, triglyceride, lipoprotein and blood pressure values were typical for adolescents of this age. Ten percent to 33% of children had elevated glucose (\>100 mg/dL), decreased high-density lipoprotein (\<40 mg/dL) or borderline/high triglyceride concentrations (\>90 mg/dL).[@R66]

Ongoing activities and future plans {#s4}
===================================

Data collected from the recently completed phase of research at 12 years of age will allow examination of the relations between environmental chemical exposures and several adolescent health outcomes of high public health importance. Specifically, we received the United States National Institutes of Environmental Health Sciences (NIEHS) funding to assess the impact of:

-   Early life PFAS exposures on early adolescent adiposity, cardiometabolic health and DNA methylation (R01 ES025214).

-   Early life PFAS and PBDE exposures on adolescent internalising behaviours and neuroimaging outcomes (R01 ES027224).

-   Early life organophosphate and novel brominated flame retardant exposures on neurodevelopment (R01 ES028277).

-   Early life PFAS and phthalate exposures on bone health (R01 ES030078).

We are planning continued follow-up of HOME Study mothers and children and hope to invite them back for an in-person study visit when children are aged 16--18 and 17--21 years. During this visit, we will pilot new methods to remotely assess children's chemical exposures and health as they become adults. Our hope is to conduct follow-up on these children throughout adulthood.

Strengths and limitations {#s5}
=========================

One major strength of the HOME Study is the detailed phenotyping of several health outcomes that emerge in adolescence and are important determinants of health and well-being in early adulthood.[@R67] Moreover, we have both maternal and child ratings of internalising symptoms and neurobehaviour, enhancing our ability to identify potential effects of chemical exposures on traits that might not be noticeable to parent-raters (eg, anxiety). A second strength is that we conducted state-of-the-art measurement of many important determinants of adolescent health to control for confounding or identify potential mediators and modifiers. Finally, we conducted an extensive longitudinal assessment of exposure to \>100 environmental chemicals or metals in gestation, infancy, childhood and adolescence.

One limitation of the HOME Study is the modest sample size, which reduces statistical power to estimate small effect sizes and limits the ability to examine clinical diagnoses. Second, and not unique to our study, is the loss to follow-up (58% follow-up at the 12-year study visit). Reassuringly, our follow-up rates have increased in the latest three phases of study visits. In addition, sociodemographic factors did not substantially differ among participants who completed the 12-year study visit compared with the original cohort. Third, we collected limited information about fathers (or father figures), who play an influential role in adolescent health. Finally, our findings may not be generalisable to other populations as our eligibility criteria were not designed to ensure that our cohort was representative of births in the study region. However, most chemical biomarker concentrations among HOME Study participants are similar to pregnant women and children in the USA during the time of enrolment and follow-up.[@R61]

Collaboration {#s6}
=============

With funding from the NIEHS, we previously pooled data from the HOME Study with three other cohorts located in California and New York City.[@R70] More recently, we jointly analysed or pooled data from the Maternal--Infant Research on Environmental Chemical (MIREC) Study,[@R73] Early Autism Risk Longitudinal Investigation (EARLI) Study[@R74] and Cincinnati Childhood Allergy and Air Pollution Study (CCAAPS).[@R75] The goals of these collaborations have been to investigate how environmental chemicals, air pollution, nutritional factors and endogenous hormones influence childhood obesity and neurobehaviour. By pooling data or conducting joint analyses, we have attempted to replicate findings across cohorts to enhance causal inference and increase sample size to study chemical mixtures or uncommon phenotypes (eg, autism spectrum disorders).

The HOME Study Principal Investigators welcome new collaborations with other investigators and have actively engaged in collaborative data-sharing projects. Interested investigators should contact Drs Joseph M Braun (joseph_braun_1\@brown.edu) and Kimberly Yolton (kimberly.yolton\@cchmc.org) to obtain additional information about the HOME Study, discuss collaborative opportunities and request a project proposal form. We are also designing a web portal that will allow exploration of study variables for the development of ancillary and secondary studies. The HOME Study Protocol Review Committee reviews proposed research projects to ensure that they do not overlap with extant projects and are an efficient use of scarce resources (eg, biospecimens).
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